Skip to main content
HairCited

Minoxidil لـ تساقط الشعر النمطي الأنثوي

A

بناءً على 67 دراسة (4 meta-analyses, 11 RCTs) بمشاركة 28,815 مشاركًا إجمالاً. 53/67 دراسة تُظهر تأثيرات إيجابية.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day مقابل: None Outcome: consensus recommendations for managing pattern hair loss التأثير: None None

المجتمع المدروس: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study مقابل: Placebo التأثير: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None مقابل: Placebo التأثير: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi مقابل: Placebo التأثير: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None مقابل: Placebo التأثير: None None

Key Statistics

111

الدراسات

37800

المشاركون

Positive

A

التقييم

Referenced Papers

Australian prescriber 2025 2 اقتباسات
Annals of dermatology 2025
SAGE open medical … 2024 3 اقتباسات
Drugs 2023 221 اقتباسات
Anais brasileiros de … 2023 29 اقتباسات
Skin appendage disorders 2023 7 اقتباسات
Journal of cosmetic … 2023 3 اقتباسات
The Journal of … 2022 170 اقتباسات
Faculty reviews 2022 44 اقتباسات
Journal of cosmetic … 2022 7 اقتباسات
Journal of the … 2021 42 اقتباسات
American journal of … 2020 127 اقتباسات
International journal of … 2020 58 اقتباسات
Indian dermatology online … 2020 31 اقتباسات
Journal of cosmetic … 2019 34 اقتباسات
Actas dermo-sifiliograficas 2019 5 اقتباسات
International journal of … 2018 129 اقتباسات
Australian journal of … 2018 8 اقتباسات
JAMA dermatology 2017 121 اقتباسات
The Cochrane database … 2016 18 اقتباسات
The Medical clinics … 2015 66 اقتباسات
World journal of … 2015 62 اقتباسات
Seminars in cutaneous … 2015 27 اقتباسات
Seminars in cutaneous … 2015 20 اقتباسات
Clinical obstetrics and … 2015 9 اقتباسات
Current problems in … 2015 8 اقتباسات
Skin therapy letter 2014 29 اقتباسات
Journal of drugs … 2014 26 اقتباسات
Dermatologic clinics 2013 78 اقتباسات
International journal of … 2013 61 اقتباسات
Indian journal of … 2013 16 اقتباسات
International journal of … 2013
The British journal … 2012 48 اقتباسات
The Cochrane database … 2012 15 اقتباسات
Skinmed 2012 5 اقتباسات
The Australasian journal … 2011 44 اقتباسات
Indian journal of … 2009 109 اقتباسات
Seminars in cutaneous … 2009 4 اقتباسات
American family physician 2009
Journal of the … 2008 290 اقتباسات
The Australasian journal … 2007 32 اقتباسات
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
Journal of the … 2005 247 اقتباسات
The British journal … 2005 205 اقتباسات
The journal of … 2003 102 اقتباسات
Clinical and experimental … 2002 61 اقتباسات
Therapeutische Umschau. Revue … 2002 4 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

topical:
2-5% solution, twice daily

الحد الأعلى: 5% topical solution

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

أفضل وقت للتناول: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

التفاعلات المعروفة

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

الحد الأقصى المسموح به: 5% topical solution

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Minoxidil help with تساقط الشعر النمطي الأنثوي?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support تساقط الشعر النمطي الأنثوي management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for تساقط الشعر النمطي الأنثوي?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and تساقط الشعر النمطي الأنثوي?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.